Inventor · disambiguated record
Esteban Masuda
Also filed as: MASUDA ESTEBAN
84 granted patents·28 pending applications·380 citations·filing 2001–2025
99Inventor score
Top patents by PatentIndex Score
112 records- 0197US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 0297US8163902B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2007·Granted Apr 24, 2012·35 cites·22 claims
- 0397US7989448B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Aug 2, 2011·35 cites·20 claims
- 0497US7538108B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted May 26, 2009·43 cites·19 claims
- 0596US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 0696US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 0796US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 0895US8211888B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2011·Granted Jul 3, 2012·19 cites·9 claims
- 0993US11377428B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 1093US11370765B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 1193US11370764B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 1291US7659280B22,4-pyrimidinediamine compounds for treating or preventing autoimmune diseasesRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Feb 9, 2010·19 cites·17 claims
- 1390US8785437B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·7 cites·8 claims
- 1489US2025034100A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1588US11919890B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·1 cites·18 claims
- 1688US11110082B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 7, 2021·2 cites·28 claims
- 1788US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 1888US8476263B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2012·Granted Jul 2, 2013·5 cites·10 claims
- 1987US8227455B2Methods of treating cell proliferative disordersMASUDA ESTEBAN·Filed 2006·Granted Jul 24, 2012·14 cites·40 claims
- 2086US7576053B2Methods and compositions for treating degenerative bone disordersRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 18, 2009·15 cites·31 claims
- 2185US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 2285US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 2385US8053434B2Kinase inhibitors and their usesRIGEL PHARMACEUTICALS INC·Filed 2009·Granted Nov 8, 2011·5 cites·42 claims
- 2484US12116354B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Oct 15, 2024·0 cites·21 claims
- 2584US9737554B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Aug 22, 2017·2 cites·11 claims
- 2684US9532998B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2016·Granted Jan 3, 2017·2 cites·24 claims
- 2784US9266912B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·3 cites·24 claims
- 2883US10434096B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·2 cites·6 claims
- 2983US9682976B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·3 cites·55 claims
- 3083US9169249B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 27, 2015·4 cites·17 claims
- 3182US10577381B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 3, 2020·1 cites·24 claims
- 3281US12384775B2Pyrimid-2-yl-pyrazole compounds as IRAK inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Aug 12, 2025·0 cites·22 claims
- 3381US10130623B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 20, 2018·2 cites·39 claims
- 3481US9913843B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·3 cites·5 claims
- 3581US9593082B2Compositions and methods for inhibition of the JAK pathwayARGADE ANKUSH·Filed 2008·Granted Mar 14, 2017·3 cites·17 claims
- 3681US9283238B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Mar 15, 2016·2 cites·7 claims
- 3781US9181222B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·4 cites·18 claims
- 3881US8710223B2Protein kinase C inhibitors and uses thereofHOLLAND SACHA·Filed 2011·Granted Apr 29, 2014·7 cites·2 claims
- 3981US8530466B2Use of 2,4-pyrimidinediamines for the treatment of atherosclerosisMASUDA ESTEBAN·Filed 2009·Granted Sep 10, 2013·8 cites·1 claims
- 4081US2024217958A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4180US11220496B2Compounds and method for treating autoimmune diseasesRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jan 11, 2022·1 cites·20 claims
- 4280US8912170B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·2 cites·28 claims
- 4380US7425418B2Compounds that modulate processes associated with IgE productionRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Sep 16, 2008·3 cites·20 claims
- 4479US8962643B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Feb 24, 2015·3 cites·25 claims
- 4579US8445485B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2012·Granted May 21, 2013·2 cites·23 claims
- 4679US7601713B2Kinase inhibitors and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Oct 13, 2009·2 cites·42 claims
- 4779US2022218705A1Compounds and method for treating autoimmune diseasesRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4878US8334297B22,4-pyrimidinediamine compounds for treatment of inflammatory disordersLI HUI·Filed 2010·Granted Dec 18, 2012·5 cites·26 claims
- 4978US2025333408A1Pyrimid-2-yl-pyrazole compounds as irak inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 5077US7056687B2Methods and compositions for screening for altered cellular phenotypesRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·4 cites·59 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Esteban Masuda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →